| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/11/2006 | US7074614 Clock gene BMAL2 |
| 07/11/2006 | US7074575 Anticancer activity of IL- 19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of ovarian cancer cells for ovarian |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof |
| 07/11/2006 | US7074438 Compositions for oral delivery of nutrients and pharmaceuticals |
| 07/11/2006 | US7074432 Drug , biocompatible polymer and biphosphonate compound |
| 07/11/2006 | US7074431 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil |
| 07/11/2006 | US7074427 Comprises a shell with a gas enclosed in the internal space thereof as well as a substance capable of generating active oxygen species upon irradiation of the shell with an ultrasound as retained or contained in shell; therapy |
| 07/11/2006 | US7074420 Cosmetic treatment using a new retinoid |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074405 antibody binds target tissue and conjugate carrying epitope (haptens) |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074402 Treating different types of neuronal dysfunction, including stroke, Alzheimer's disease, Parkinson's disease, Huntington disease, neuroimmunological disorders such as multiple scelrosis |
| 07/11/2006 | US7074397 Method for enhancing proliferation or differentiation of a cell using ob protein |
| 07/11/2006 | US7074392 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent |
| 07/11/2006 | US7074389 For therapy and prophylaxis, side effect reduction |
| 07/11/2006 | US7074388 Water stabilized medicinal aerosol formulation |
| 07/11/2006 | US7073512 Adhesion prevention and an endoscopic insufflation system therefor |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/11/2006 | CA2157921C Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| 07/06/2006 | WO2006070804A1 Method of inhibiting telomerase activity and inhibitor |
| 07/06/2006 | WO2006070742A1 Tolerance development inhibitor for narcotic analgesic agent |
| 07/06/2006 | WO2006070718A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | WO2006043036A3 Treatment of diabetes |
| 07/06/2006 | WO2005123098A3 Preventing gastrointestinal side-effects with strontium salts |
| 07/06/2006 | US20060149182 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060148908 Supressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 07/06/2006 | US20060148900 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 07/06/2006 | US20060148885 Medicinal composition |
| 07/06/2006 | US20060148839 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 07/06/2006 | US20060148827 administering adenosine receptor antagonist; side effect reduction; Parkinson's disease |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148804 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148786 Medicine for treating gastrointestinal disorder including irritable bowel syndrome |
| 07/06/2006 | US20060148761 Lipids |
| 07/06/2006 | US20060148713 Use of exendins and agonists thereof for the reduction of food intake |
| 07/06/2006 | US20060148712 Monocyte chemoattractant activity of galectin-3 |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148707 Use of ligands to GABA beta receptors |
| 07/06/2006 | US20060148697 Administering physiological agent that decreases or regulates blood or tissue levels, expression, production, function, or activity of luteinizing hormone (LH), LH receptors, follicle stimulating hormone (FSH), FSH receptor, androgenic steroid, androgenicsteroid receptors, an activin, activin receptor |
| 07/06/2006 | US20060148694 Inhibition of stress-induced ligand-dependent egfr activation |
| 07/06/2006 | US20060148693 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148683 Detection and treatment of intravascular lesions |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148675 Methods of reducing angiogenesis |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147914 evaluating ability of agents to modulate Homer protein activity, Homer protein/immunophilin-peptidylproline cis-trans isomerase interaction, and/or Homer protein/proline-type Homer ligand consensus sequence interaction to identify agents for treatment; modulation of immunosupression and neuroprotection |
| 07/06/2006 | US20060147902 Yeast screens for treatment of human disease |
| 07/06/2006 | US20060147552 Use of iron for treating attention deficit hyperactivity disorder in children |
| 07/06/2006 | US20060147547 Bone enhancing composite |
| 07/06/2006 | US20060147544 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 07/06/2006 | US20060147526 Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147428 Allogeneic and xenogeneic transplantation |
| 07/06/2006 | US20060147391 Composition for enhancing oral health |
| 07/06/2006 | US20060147384 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 07/06/2006 | US20060147382 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| 07/06/2006 | US20060147371 Sustained delivery of chemotherapeutic agent at high concentration without damaging normal cells beyond repair |
| 07/06/2006 | CA2592461A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same |
| 07/05/2006 | EP1676581A2 Polymer compositions for use in therapy |
| 07/05/2006 | EP1676576A1 Combinations comprising camptothecin and their use for the treatment of neoplastic diseases |
| 07/05/2006 | EP1676570A1 Topical pharmaceutical compositions comprising L-arginine and uses thereof |
| 07/05/2006 | EP1676551A2 Treatment of hepatitis C using hyperthermia |
| 07/05/2006 | EP1676132A1 System and method for the treatment of cancer, including cancers of the central nervous system |
| 07/05/2006 | EP1675817A1 Aminoalkanol derivatives |
| 07/05/2006 | EP1675614A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 07/05/2006 | EP1675600A2 Methods, compositions,, apparatuses containing tetrameric oxygen |
| 07/05/2006 | EP1675582A1 Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders |
| 07/05/2006 | EP1675550A2 Therapeutic regimens for administering drug combinations |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1675465A2 Improved combination bacteriolytic therapy for the treatment of tumors |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1389044A4 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| 07/05/2006 | EP1385505B1 Acne treatment with lipooxigenase inhibitors |
| 07/05/2006 | EP1368040B1 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/05/2006 | EP1313762B1 Suppressor gene |
| 07/05/2006 | EP1259240B1 Agents, such as nicotinamide or cadpr for the treatment of skin disorders |
| 07/05/2006 | EP1248626B1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/05/2006 | EP1234582B1 Concomitant drugs for treating glaucoma |
| 07/05/2006 | EP1183026B1 Improved pharmaceutical formulations comprising ritonavir |
| 07/05/2006 | EP1105485B1 Human il-1 epsilon dna and polypeptides |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment |
| 07/05/2006 | EP1067958B1 Treatment of cardiac hypertrophy |
| 07/05/2006 | EP0986164B1 Brush holder |
| 07/05/2006 | EP0923740B1 Methods and compositions for the detection of cervical cancer |
| 07/05/2006 | CN1799002A Laser projector |
| 07/05/2006 | CN1798975A Method of screening drug with the use of 67 KDA laminin receptor and drug obtained thereby |
| 07/05/2006 | CN1798754A Synthesis of high molecular weight iron-saccharidic complexes |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/05/2006 | CN1798577A Method of inducing differentiation and proliferating regulatory t cell by anti-CD52 antibody and medicinal composition therefor |